Clinical Trial Update: A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating romosozumab in South Korean women with postmenopausal osteoporosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2019-07-05